KROS Stock-Based Compensation
Keros Therapeutics Inc · Stock-Based Compensation
KROS Stock-Based Compensation
Latest reported$22.87Mperiod ending
KROS Stock-Based Comp ($81.00K → $22.87M)
Annual stock-based compensation
High-resolution chart · PNG
KROS stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 28,696,000 | |
| 34,872,000 | |
| 28,763,000 | |
| 18,682,000 | |
| 11,722,000 | |
| 4,097,000 | |
| 0 | |
| 81,000 |